Pular para o conteúdo
Merck
  • [Comparative study of the hemato-protective effect of Dicarbamine and Leykostime in experimental radiation damage to the blood system].

[Comparative study of the hemato-protective effect of Dicarbamine and Leykostime in experimental radiation damage to the blood system].

Voprosy onkologii (2013-07-03)
I Ia Moiseeva, A I Zinov'ev, L V Ionicheva, S A Nikishin, V E Nebol'sin
RESUMO

There was studied the influence Dicarbamine and Leykostime on peripheral blood leukocyte composition of rabbits in experimental radiogenic damage to the blood system. Dicarbamine significantly insured the safety of circulating red blood cells, prevented the development of severe postradiation thrombocytopenia, reduced postradiation leukocytopenia, and accelerated the recovery of peripheral blood leukocytes to the initial level by segmented neutrophils and lymphocytes. Leukostime ensured the safety of peripheral blood leukocytes however was less effective than Dicarbamine to prevent postradiation deficit of circulating red blood cells and thrombocytes.

MATERIAIS
Número do produto
Marca
Descrição do produto

Filgrastim, European Pharmacopoeia (EP) Reference Standard